Crude | Adjusteda | |||
---|---|---|---|---|
OR | 95% CI | OR | 95% CI | |
1-year disease parameters | ||||
Erosions presentb | 6.16 | (2.77–13.73) | NA | NA |
First-year progression (≥ 1 unit increase in SHS) | 5.25 | (1.90–14.47) | NA | NA |
First-year change in SHS (per SD)c | 2.31 | (1.51–3.54) | NA | NA |
RRP during first year | 6.87 | (2.98–15.82) | NA | NA |
DAS28 (per SD)c | 2.89 | (1.81–4.61) | 2.54 | (1.54–4.19) |
Disease activityd | ||||
Low (reference) | 1.00 | 1.00 | ||
Moderate | 7.13 | (2.02–25.13) | 6.14 | (1.68–22.40) |
High | 13.25 | (3.11–56.44) | 9.05 | (1.91–42.84) |
HAQ (per SD)c | 1.62 | (1.12–2.33) | 1.75 | (1.18–2.61) |
ESR (per SD)c | 2.82 | (1.77–4.50) | 2.10 | (1.30–3.37) |
CRP below 75th percentile (reference) | 1.00 | 1.00 | ||
CRP above 75th percentile (> 10 mg/l) | 10.32 | (4.44–24.00) | 6.98 | (2.85–17.14) |
Swollen joint count (per SD)c | 1.97 | (1.35–2.87) | 1.79 | (1.18–2.70) |
Tender joint count (per SD)c | 1.49 | (1.01–2.19) | 1.46 | (0.94–2.29) |
Patient’s global assessment (VAS; per SD)C | 1.59 | (1.08–2.34) | 1.71 | (1.10–2.66) |
Pain (VAS; per SD)c | 1.71 | (1.16–2.52) | 1.86 | (1.19–2.91) |